NEKTAR THERAPEUTICS

Nasdaq:NKTR

Pharmaceutical Preparations·SAN FRANCISCO, CA

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/13/26	→
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/8/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/14/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
↓

Earnings Releases (8-K)

29 shown

Filed	Period
3/12/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/12/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

51 shown

Filed	Type	Description
2/13/26	Agreement	Entry into a Material Definitive Agreement	→
2/10/26	Reg FD	Regulation FD Disclosure	→
2/10/26	Reg FD	Regulation FD Disclosure	→
1/27/26	Reg FD	Regulation FD Disclosure	→
12/16/25	Reg FD	Regulation FD Disclosure	→
11/21/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

25 shown

Filed	Form	Description
2/13/26	424B5	424B5	→
2/10/26	424B5	424B5	→
11/12/25	S-8	REGISTRATION STATEMENT	→
11/12/25	424B5	424B5	→
11/12/25	S-3ASR	S-3ASR	→
8/8/25	S-8	REGISTRATION STATEMENT	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

10-K

Mar 13, 2026

0001193125-26-10454710-K

Dec 31, 2025

15.6 MB

8-K

Mar 12, 2026

0001213900-26-027026CURRENT REPORT

Mar 12, 2026

293.7 KB

SCHEDULE 13G

Mar 6, 2026

0000315066-26-000649

—

11.3 KB

Feb 20, 2026

0001193125-26-0618864

Feb 18, 2026

5.3 KB

Feb 20, 2026

0001193125-26-0618854

Feb 18, 2026

6.0 KB

144

Feb 18, 2026

0001959173-26-001149

—

5.2 KB

144

Feb 18, 2026

0001959173-26-001135

—

5.7 KB

SCHEDULE 13G/A

Feb 13, 2026

0001446580-26-000040

—

14.7 KB

8-K

Feb 13, 2026

0001193125-26-0493788-K

Feb 11, 2026

583.9 KB

424B5

Feb 13, 2026

0001193125-26-049191424B5

—

679.0 KB

424B5

Feb 10, 2026

0001193125-26-044760424B5

—

540.9 KB

8-K

Feb 10, 2026

0001193125-26-0447518-K

Feb 10, 2026

128.0 KB

8-K

Feb 10, 2026

0001193125-26-0437558-K

Feb 10, 2026

5.7 MB

SCHEDULE 13G

Jan 30, 2026

0000102909-26-000212

—

7.0 KB

8-K

Jan 27, 2026

0001213900-26-008210CURRENT REPORT

Jan 27, 2026

183.0 KB

Jan 22, 2026

0001193125-26-0198434

Jan 20, 2026

5.2 KB

144

Jan 20, 2026

0001959173-26-000377

—

6.1 KB

Dec 23, 2025

0001193125-25-3311894

Dec 22, 2025

7.1 KB

Dec 23, 2025

0001193125-25-3311874

Dec 22, 2025

7.8 KB

8-K

Dec 16, 2025

0001193125-25-3200098-K

Dec 16, 2025

16.8 MB

Nov 25, 2025

0001193125-25-2978554

Nov 21, 2025

10.2 KB

Nov 25, 2025

0001193125-25-2978524

Nov 21, 2025

10.4 KB

Nov 25, 2025

0001193125-25-2978504

Nov 21, 2025

10.8 KB

144

Nov 25, 2025

0001959173-25-007276

—

6.9 KB

144

Nov 25, 2025

0001959173-25-007275

—

4.5 KB

25 filings shown

Filed	Form	Description
4/25/25	DEF 14A	DEF 14A	→
4/15/25	PRE 14A	PRE 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

NEKTAR THERAPEUTICS

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/20/26	4	4	→
2/20/26	4	4	→
1/22/26	4	4	→
12/23/25	4	4	→
12/23/25	4	4	→
11/25/25	4	4	→
↓

Filed	Form	Description
3/6/26	SCHEDULE 13G	SCHEDULE 13G	→
2/18/26	144	144	→
2/18/26	144	144	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/30/26	SCHEDULE 13G	SCHEDULE 13G	→
1/20/26	144	144	→
↓